
Conference Coverage
Latest Content

FDA Grants Accelerated Approval to Neladalkib in Pretreated ALK+ NSCLC

From Oncology Nurse to Care Partner: Lessons From a Couple Facing NMIBC

FDA Approves Giredestrant Plus Everolimus for ESR1-Mutated Breast Cancer

FDA Approves Generic Binimetinib for BRAF-Mutant Melanoma and NSCLC

Nurse Navigation and Long-Term Cancer Survivorship Insights

Shorts










Videos
All News

Pertuzumab-qcay is the second FDA-approved biosimilar to Perjeta, but a settlement with Genentech delays its US launch until Q3 2028.

The FDA declined to approve ivonescimab plus chemotherapy after EGFR TKI therapy, citing no statistically significant OS gain in HARMONi.

Cancer care teams are supporting more patients than ever, and oncology teams are navigating the clinical and operational realities that come with that growth.

A 5-decade SEER analysis found 5-year survival in young patients rose from 60% to 90%, yet non-Hispanic Black patients fared worst across cancers.

Nurses earn public trust through quiet acts of compassion, reassurance, and presence — a vital lifeline especially in oncology care.

Modeling projects anthracycline recipients may lose a median 9.4 life-years to age acceleration, a finding with survivorship care implications.

Oncology NPs and PAs are key to closing workforce gaps. Here’s how generalist, specialist, and hybrid APP models improve access and outcomes.

Perioperative durvalumab with enfortumab vedotin given only before cystectomy cut the risk of an EFS event by 49% in the phase 3 VOLGA trial.

With 10 years of oncology nursing experience, Lee Grabb highlights how nurse navigation, human connection, and compassion transform holistic cancer care.

Lisa Carter-Bawa, PhD, MPH, APRN, explains how blame keeps patients from lung cancer care and how nurses can counter that stigma in the community.

A study of 6 palliative care programs tied trust, proximity, and real-time communication with oncology teams to higher hospice use.

At the 10th Annual School of Nursing Oncology, faculty said nurses need fast, disease-specific updates to educate patients and manage novel therapies.

Experts detail evidence for exercise, acupuncture, and mind-body care during radiation, and the knowledge and referral gaps that limit uptake.

The PCR-based tissue assay can now identify patients with MSI-high solid tumors who may be candidates for pembrolizumab.

An 18-year analysis of a foundation program found trial-related travel, lodging, and caregiving costs varied by income, distance, and trial phase.
























































































